Scientists will receive about $1.25 million from the Center for the Advancement of Science in Space to develop an implantable device that delivers therapeutic drugs at a rate guided by remote control. The device's effectiveness will be tested aboard the International Space Station and on Earth's surface.
Researchers have broken new ground in the development of proteins that form specialized fibers used in medicine and nanotechnology. For as long as scientists have been able to create new proteins that are capable of self-assembling into fibers, their work has taken place on the nanoscale. For the first time, this achievement has been realized on the microscale - a leap of magnitude in size that presents significant new opportunities for using engineered protein fibers.
Scientists have developed new organic compounds characterized by a higher modularity, stability and efficiency, which could be applicable in the semiconductors industry for using them in electronics or lighting.
Successful techniques for cryopreserving bulk biomaterials and organ systems would transform current approaches to transplantation and regenerative medicine. However, while vitrified cryopreservation holds great promise, practical application has been limited to smaller systems (cells and thin tissues) due to diffusive heat and mass transfer limitations, which are typically manifested as devitrification and cracking failures during thaw. Now researchers leverage a clinically proven technology platform, in magnetically heated nanoparticles, to overcome this major hurdle limiting further advancement in the field of cryopreservation.
An emerging super-black nanotechnology that is to be tested for the first time this fall on the International Space Station will be applied to a complex, 3-D component critical for suppressing stray light in a new, smaller, less-expensive solar coronagraph designed to ultimately fly on the orbiting outpost or as a hosted payload on a commercial satellite.